Review



nb4 cell lines  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC nb4 cell lines
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Nb4 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 7216 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb4 cell lines/product/ATCC
    Average 99 stars, based on 7216 article reviews
    nb4 cell lines - by Bioz Stars, 2026-02
    99/100 stars

    Images

    1) Product Images from "Enlarged PML-nuclear bodies trigger conflicting cell cycle signal-mediated cytotoxicity in leukemia cells"

    Article Title: Enlarged PML-nuclear bodies trigger conflicting cell cycle signal-mediated cytotoxicity in leukemia cells

    Journal: Cell Death & Disease

    doi: 10.1038/s41419-025-07911-7

    NB4 and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Figure Legend Snippet: NB4 and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).

    Techniques Used: Expressing, Staining, Incubation



    Similar Products

    99
    ATCC nb4 cell lines
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Nb4 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb4 cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    nb4 cell lines - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    94
    CLS Cell Lines Service GmbH human myeloid nb4
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Human Myeloid Nb4, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human myeloid nb4/product/CLS Cell Lines Service GmbH
    Average 94 stars, based on 1 article reviews
    human myeloid nb4 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    96
    DSMZ nb4 cells
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Nb4 Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb4 cells/product/DSMZ
    Average 96 stars, based on 1 article reviews
    nb4 cells - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    DSMZ apl derived nb4 cell line
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Apl Derived Nb4 Cell Line, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/apl derived nb4 cell line/product/DSMZ
    Average 96 stars, based on 1 article reviews
    apl derived nb4 cell line - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    DSMZ experimental models: cell lines nb4
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Experimental Models: Cell Lines Nb4, supplied by DSMZ, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/experimental models: cell lines nb4/product/DSMZ
    Average 90 stars, based on 1 article reviews
    experimental models: cell lines nb4 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Pasteur Institute nb4 cell line
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Nb4 Cell Line, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb4 cell line/product/Pasteur Institute
    Average 90 stars, based on 1 article reviews
    nb4 cell line - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Procell Inc nb4 cell line cl-0676
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Nb4 Cell Line Cl 0676, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb4 cell line cl-0676/product/Procell Inc
    Average 90 stars, based on 1 article reviews
    nb4 cell line cl-0676 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    China Center for Type Culture Collection aml cell line nb4
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Aml Cell Line Nb4, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aml cell line nb4/product/China Center for Type Culture Collection
    Average 90 stars, based on 1 article reviews
    aml cell line nb4 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    AcceGen Biotechnology nb4 cell line
    <t>NB4</t> and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).
    Nb4 Cell Line, supplied by AcceGen Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb4 cell line/product/AcceGen Biotechnology
    Average 93 stars, based on 1 article reviews
    nb4 cell line - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology nb4 cells
    Fig. 1. Susceptibility of <t>NB4,</t> U937 and THP-1 cells to ATO induced mitochondrial ROS formation.NB4, U937 or THP-1 (A-D) cells were pretreated for 5 min with the vehicle or 0.5 µM rotenone and incubated for 6 h with increasing concentrations of ATO (A, B), or NaAsO2 (C, D). After treatments, the cells were analyzed for MitoSOX red- (A, C) or DHR- (B, D) fluorescence, as detailed in the Materials and Methods section. In other experiments, U937 were incubated for 6 h with 5 µM ATO, alone or associated with rotenone, and analyzed for MitoSOX red- (E) or DHR- (F) fluorescence. Results represent the means ± SD calculated from three separate experiments. *P < 0.05, * *P < 0.01, compared with untreated cells. #P 0.05, ##P < 0.01 compared with ATO or NaAsO2 treated cells (one-way ANOVA followed by Tukey test).
    Nb4 Cells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nb4 cells/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    nb4 cells - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    Image Search Results


    NB4 and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).

    Journal: Cell Death & Disease

    Article Title: Enlarged PML-nuclear bodies trigger conflicting cell cycle signal-mediated cytotoxicity in leukemia cells

    doi: 10.1038/s41419-025-07911-7

    Figure Lengend Snippet: NB4 and HL60 cell lines were treated with 1 μM ATRA. a The expression of CD38 and CD11b on non-treated cells (black dots) and cells treated with ATRA for 24 h (blue dots) or 48 h (red dots) are shown. Representative data from three independent experiments are shown. b NBT staining of NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells served as controls. Representative images and mean + SD of the percentage of NBT-positive cells, calculated from eight randomly selected fields across three independent experiments, are shown. c Cell growth in drug-free medium following prior incubation with ATRA for 24 or 48 h ( n = 4). DMSO-treated cells for 24 h served as controls. The fold change in cell number was calculated by dividing the values at each time point by the values at day 0. d Immunofluorescent staining for PML-NBs in NB4 and HL60 cells 48 h after treatment with ATRA. DMSO-treated cells were used as controls. Representative images and mean + SD of the number of PML-NBs per nucleus are shown ( n = 4). ** P < 0.01; N.S., no significant difference (two-sided Student’s t -test).

    Article Snippet: HL60, MV4-11, and NB4 cell lines were purchased from ATCC (Manassas, VA).

    Techniques: Expressing, Staining, Incubation

    Fig. 1. Susceptibility of NB4, U937 and THP-1 cells to ATO induced mitochondrial ROS formation.NB4, U937 or THP-1 (A-D) cells were pretreated for 5 min with the vehicle or 0.5 µM rotenone and incubated for 6 h with increasing concentrations of ATO (A, B), or NaAsO2 (C, D). After treatments, the cells were analyzed for MitoSOX red- (A, C) or DHR- (B, D) fluorescence, as detailed in the Materials and Methods section. In other experiments, U937 were incubated for 6 h with 5 µM ATO, alone or associated with rotenone, and analyzed for MitoSOX red- (E) or DHR- (F) fluorescence. Results represent the means ± SD calculated from three separate experiments. *P < 0.05, * *P < 0.01, compared with untreated cells. #P 0.05, ##P < 0.01 compared with ATO or NaAsO2 treated cells (one-way ANOVA followed by Tukey test).

    Journal: Pharmacological research

    Article Title: Unveiling the link between NADPH oxidase 2 activation and mitochondrial superoxide formation in leukemic cell killing induced by arsenic trioxide.

    doi: 10.1016/j.phrs.2024.107554

    Figure Lengend Snippet: Fig. 1. Susceptibility of NB4, U937 and THP-1 cells to ATO induced mitochondrial ROS formation.NB4, U937 or THP-1 (A-D) cells were pretreated for 5 min with the vehicle or 0.5 µM rotenone and incubated for 6 h with increasing concentrations of ATO (A, B), or NaAsO2 (C, D). After treatments, the cells were analyzed for MitoSOX red- (A, C) or DHR- (B, D) fluorescence, as detailed in the Materials and Methods section. In other experiments, U937 were incubated for 6 h with 5 µM ATO, alone or associated with rotenone, and analyzed for MitoSOX red- (E) or DHR- (F) fluorescence. Results represent the means ± SD calculated from three separate experiments. *P < 0.05, * *P < 0.01, compared with untreated cells. #P 0.05, ##P < 0.01 compared with ATO or NaAsO2 treated cells (one-way ANOVA followed by Tukey test).

    Article Snippet: NB4 cells were transfected with a pool of 4 target-specific p47phox siRNAs (sc-29422, Santa Cruz Biotechnology).

    Techniques: Incubation, Fluorescence

    Fig. 2. Clinically relevant concentrations of ATO stimulate phosphorylation of phospho p47phox in NB4 but not in U937 or THP-1 cells.NB4 (A, D), U937 (B, E) or THP-1 (C, F) cells were incubated for 6 h with 0.5 or 1 µM ATO. In other experiments, NB4 (G) or U937 (H) cells were treated for 6 h with 2.5 NaAsO2 or 5 µM ATO, respectively. PMA (0.162 µM, 15 min) was used as a positive control. After treatments, the cells were analyzed for phospho p47phox expression (A-H). The blot, representative of three separate experiments, was re-probed for p47phox. Representative micrographs providing immunocytochemical evidence of p47phox phos phorylation are also reported in panel D (NB4 cells), E (U937 cells) and F (THP-1 cells). After treatments, the cells were fixed and processed as detailed in Material and Methods. Scale bar represents 20 µm. Results represent the means ± SD calculated from three separate experiments. *P < 0.05, * *P < 0.01, compared with untreated cells (one-way ANOVA followed by Dunnett’s test).

    Journal: Pharmacological research

    Article Title: Unveiling the link between NADPH oxidase 2 activation and mitochondrial superoxide formation in leukemic cell killing induced by arsenic trioxide.

    doi: 10.1016/j.phrs.2024.107554

    Figure Lengend Snippet: Fig. 2. Clinically relevant concentrations of ATO stimulate phosphorylation of phospho p47phox in NB4 but not in U937 or THP-1 cells.NB4 (A, D), U937 (B, E) or THP-1 (C, F) cells were incubated for 6 h with 0.5 or 1 µM ATO. In other experiments, NB4 (G) or U937 (H) cells were treated for 6 h with 2.5 NaAsO2 or 5 µM ATO, respectively. PMA (0.162 µM, 15 min) was used as a positive control. After treatments, the cells were analyzed for phospho p47phox expression (A-H). The blot, representative of three separate experiments, was re-probed for p47phox. Representative micrographs providing immunocytochemical evidence of p47phox phos phorylation are also reported in panel D (NB4 cells), E (U937 cells) and F (THP-1 cells). After treatments, the cells were fixed and processed as detailed in Material and Methods. Scale bar represents 20 µm. Results represent the means ± SD calculated from three separate experiments. *P < 0.05, * *P < 0.01, compared with untreated cells (one-way ANOVA followed by Dunnett’s test).

    Article Snippet: NB4 cells were transfected with a pool of 4 target-specific p47phox siRNAs (sc-29422, Santa Cruz Biotechnology).

    Techniques: Phospho-proteomics, Incubation, Positive Control, Expressing

    Fig. 3. Pharmacological inhibition of NOX 2 activity suppresses mitochondrial ROS formation induced by ATO in NB4 cells.NB4 cells were pretreated for 5 min with the vehicle, 10 µM apocynin, or 1 µM DPI, and exposed for 15 min to 0.162 µM PMA. After treatments, the cells were analyzed for phospho p47phox expression (A) or DHR-fluorescence (B). NB4 cells pretreated as indicated above or with rotenone, were exposed for 6 h to 1 µM ATO. After treatments, the cells were analyzed for phospho p47phox expression (C), MitoSOX red- (D) or DHR- (E) fluorescence. In other experiments, the cells were pretreated with the vehicle, rotenone, apocynin or DPI, incubated for 6 h with 2.5 (F, G) or 5 µM (H-L) NaAsO2 and finally analyzed for MitoSOX red- (F, I) and DHR- (G, L) fluorescence, or for phospho p47phox

    Journal: Pharmacological research

    Article Title: Unveiling the link between NADPH oxidase 2 activation and mitochondrial superoxide formation in leukemic cell killing induced by arsenic trioxide.

    doi: 10.1016/j.phrs.2024.107554

    Figure Lengend Snippet: Fig. 3. Pharmacological inhibition of NOX 2 activity suppresses mitochondrial ROS formation induced by ATO in NB4 cells.NB4 cells were pretreated for 5 min with the vehicle, 10 µM apocynin, or 1 µM DPI, and exposed for 15 min to 0.162 µM PMA. After treatments, the cells were analyzed for phospho p47phox expression (A) or DHR-fluorescence (B). NB4 cells pretreated as indicated above or with rotenone, were exposed for 6 h to 1 µM ATO. After treatments, the cells were analyzed for phospho p47phox expression (C), MitoSOX red- (D) or DHR- (E) fluorescence. In other experiments, the cells were pretreated with the vehicle, rotenone, apocynin or DPI, incubated for 6 h with 2.5 (F, G) or 5 µM (H-L) NaAsO2 and finally analyzed for MitoSOX red- (F, I) and DHR- (G, L) fluorescence, or for phospho p47phox

    Article Snippet: NB4 cells were transfected with a pool of 4 target-specific p47phox siRNAs (sc-29422, Santa Cruz Biotechnology).

    Techniques: Inhibition, Activity Assay, Expressing, Fluorescence, Incubation

    Fig. 4. ATO fails to promote mitochondrial ROS formation in NB4 cells with downregulated p47phox expression.NB4 control cells, transfected with scrambled or p47phox siRNA, were lysed and analyzed by Western blotting 48 h post-transfection using anti-p47phox antibody. The relative band intensity of p47phox is depicted in the top bar chart (A). GADPH was accounted for loading control. Results represent the means ± SD calculated from three separate experiments. *P < 0.05, compared with control cells (one-way ANOVA followed by Dunnett’s test).Cells transfected with scrambled or p47phox specific siRNA were pretreated for 5 min with the vehicle, apocynin, or DPI and exposed for either 15 min to PMA (B) or 6 h to 1 µM ATO (C, D). In some experiments, rotenone was added to the cultures 5 min before ATO. After treatments, the cells were analyzed for DHR- (B, C) or MitoSOX red- (D) fluorescence. Results represent the means ± SD calculated from three separate ex periments. *P < 0.05, * *P < 0.01, compared with untreated cells. #P < 0.05, ##P < 0.01 compared with ATO treated cells. $P < 0.05, $$P < 0.01 compared with treated scrambled siRNA cells (ANOVA followed by Tukey test).

    Journal: Pharmacological research

    Article Title: Unveiling the link between NADPH oxidase 2 activation and mitochondrial superoxide formation in leukemic cell killing induced by arsenic trioxide.

    doi: 10.1016/j.phrs.2024.107554

    Figure Lengend Snippet: Fig. 4. ATO fails to promote mitochondrial ROS formation in NB4 cells with downregulated p47phox expression.NB4 control cells, transfected with scrambled or p47phox siRNA, were lysed and analyzed by Western blotting 48 h post-transfection using anti-p47phox antibody. The relative band intensity of p47phox is depicted in the top bar chart (A). GADPH was accounted for loading control. Results represent the means ± SD calculated from three separate experiments. *P < 0.05, compared with control cells (one-way ANOVA followed by Dunnett’s test).Cells transfected with scrambled or p47phox specific siRNA were pretreated for 5 min with the vehicle, apocynin, or DPI and exposed for either 15 min to PMA (B) or 6 h to 1 µM ATO (C, D). In some experiments, rotenone was added to the cultures 5 min before ATO. After treatments, the cells were analyzed for DHR- (B, C) or MitoSOX red- (D) fluorescence. Results represent the means ± SD calculated from three separate ex periments. *P < 0.05, * *P < 0.01, compared with untreated cells. #P < 0.05, ##P < 0.01 compared with ATO treated cells. $P < 0.05, $$P < 0.01 compared with treated scrambled siRNA cells (ANOVA followed by Tukey test).

    Article Snippet: NB4 cells were transfected with a pool of 4 target-specific p47phox siRNAs (sc-29422, Santa Cruz Biotechnology).

    Techniques: Expressing, Control, Transfection, Western Blot, Fluorescence

    Fig. 5. Low mitochondrial ROS formation induced by ATO in resistant cells is due to poor activation of NOX 2.U937 (A), THP-1 (B) or p47phox siRNA trans fected NB4 (C) cells were pretreated for 5 min with the vehicle, rotenone, apocynin or DPI and incubated for 6 h with 0.5 or 1 µM ATO alone or associated PMA. After treatments, the cells were analyzed for MitoSOX red fluorescence. Results represent the means ± SD calculated from three separate experiments. * *P < 0.01, compared with untreated cells. ##P < 0.01 compared with ATO/ PMA treated cells (ANOVA followed by Tukey test).

    Journal: Pharmacological research

    Article Title: Unveiling the link between NADPH oxidase 2 activation and mitochondrial superoxide formation in leukemic cell killing induced by arsenic trioxide.

    doi: 10.1016/j.phrs.2024.107554

    Figure Lengend Snippet: Fig. 5. Low mitochondrial ROS formation induced by ATO in resistant cells is due to poor activation of NOX 2.U937 (A), THP-1 (B) or p47phox siRNA trans fected NB4 (C) cells were pretreated for 5 min with the vehicle, rotenone, apocynin or DPI and incubated for 6 h with 0.5 or 1 µM ATO alone or associated PMA. After treatments, the cells were analyzed for MitoSOX red fluorescence. Results represent the means ± SD calculated from three separate experiments. * *P < 0.01, compared with untreated cells. ##P < 0.01 compared with ATO/ PMA treated cells (ANOVA followed by Tukey test).

    Article Snippet: NB4 cells were transfected with a pool of 4 target-specific p47phox siRNAs (sc-29422, Santa Cruz Biotechnology).

    Techniques: Activation Assay, Incubation, Fluorescence

    Fig. 6. Clinically relevant concentrations of ATO promote mitochondrial permeability transition-dependent apoptosis in susceptible NB4 cells. NB4 control cells, and NB4 cells previously transfected with scrambled or specific p47phox siRNA, were pretreated for 5 min with the vehicle, rotenone, apocynin or 0.5 µM CsA and incubated for 6 (A), 9 (B, C) or 14 (D, E, F) h with 1 µM ATO. After treatments, the cells were analyzed for NAO-fluorescence (A) MitoTracker red CMXRos- fluorescence (B), cytochrome c (Cyt c) localization (C), caspase 3 activity (D) and apoptotic DNA fragmentation/condensation by both the Hoechst (E) and comet (F) assays. * *P < 0.01, compared with untreated cells. ##P < 0.01 compared with ATO treated cells. $$P < 0.01 compared with ATO treated scrambled siRNA cells (one-way ANOVA followed by Tukey test).

    Journal: Pharmacological research

    Article Title: Unveiling the link between NADPH oxidase 2 activation and mitochondrial superoxide formation in leukemic cell killing induced by arsenic trioxide.

    doi: 10.1016/j.phrs.2024.107554

    Figure Lengend Snippet: Fig. 6. Clinically relevant concentrations of ATO promote mitochondrial permeability transition-dependent apoptosis in susceptible NB4 cells. NB4 control cells, and NB4 cells previously transfected with scrambled or specific p47phox siRNA, were pretreated for 5 min with the vehicle, rotenone, apocynin or 0.5 µM CsA and incubated for 6 (A), 9 (B, C) or 14 (D, E, F) h with 1 µM ATO. After treatments, the cells were analyzed for NAO-fluorescence (A) MitoTracker red CMXRos- fluorescence (B), cytochrome c (Cyt c) localization (C), caspase 3 activity (D) and apoptotic DNA fragmentation/condensation by both the Hoechst (E) and comet (F) assays. * *P < 0.01, compared with untreated cells. ##P < 0.01 compared with ATO treated cells. $$P < 0.01 compared with ATO treated scrambled siRNA cells (one-way ANOVA followed by Tukey test).

    Article Snippet: NB4 cells were transfected with a pool of 4 target-specific p47phox siRNAs (sc-29422, Santa Cruz Biotechnology).

    Techniques: Permeability, Control, Transfection, Incubation, Fluorescence, Activity Assay